| Osamuede Precious Idemudia, | |
|
41521 W 11 Mile Rd, Novi, MI 48375-1803 | |
| (248) 299-0030 | |
| Not Available |
| Full Name | Osamuede Precious Idemudia |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 41521 W 11 Mile Rd, Novi, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013442748 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 4703117411 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Osamuede Precious Idemudia, 41521 W 11 Mile Rd, Novi, MI 48375-1803 Ph: (248) 299-0030 | Osamuede Precious Idemudia, 41521 W 11 Mile Rd, Novi, MI 48375-1803 Ph: (248) 299-0030 |
News Archive
Researchers at the Case Western Reserve University School of Medicine have identified a new target in development of Alzheimer's disease (AD) that could lead to therapies focused on treating the neurodegenerative condition early in its progression.
Baxter International Inc. announced today that it has entered into a definitive agreement to acquire privately-held Prism Pharmaceuticals, Inc., a specialty pharmaceutical company based in King of Prussia, PA. Prism Pharmaceuticals has developed and received U.S. Food and Drug Administration (FDA) approval for multiple presentations of NEXTERONE® (amiodarone HCl), an antiarrhythmic agent.
Recent advances in immunotherapy have allowed doctors at the University of Colorado Cancer Center to more effectively treat melanomas that spread to other parts of the body. Immunotherapy drugs such as checkpoint inhibitors, which are commonly used to treat melanomas, work to strengthen a patient's immune system so that it can prevent a tumor from "turning off" the ability of the immune system to fight it.
Research led by T. Cooper Woods, PhD, Assistant Professor of Pharmacology and Experimental Therapeutics at LSU Health Sciences Center New Orleans, and Director of the Molecular Cardiology Research Laboratory at Ochsner Clinic Foundation, has identified the mechanism of how a drug commonly used on stents to prevent reclosure of coronary arteries, regulates cell movement which is critical to wound healing and the progression of diseases like cancer.
Liver and kidney transplant recipients have a higher risk of severe COVID-19 and/or death should they become infected because the medication they take to ensure a successful transplant suppresses their immune systems.
› Verified 1 days ago
Estelle May, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 41521 W 11 Mile Rd, Novi, MI 48375 Phone: 248-299-0030 | |
Deborah L Fleming, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 41521 W 11 Mile Rd, Novi, MI 48375 Phone: 248-299-0030 | |
Sarah Watson, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 41621 W 11 Mile Rd, Novi, MI 48375 Phone: 248-299-0030 | |
Yolonda Cook, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 41521 W 11 Mile Rd, Novi, MI 48375 Phone: 248-299-0030 | |
Marlena Shaw, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 41621 W 11 Mile Rd, Novi, MI 48375 Phone: 248-299-0030 | |
Mary Sue Truesdell, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 41621 W 11 Mile Rd, Novi, MI 48375 Phone: 248-299-0030 |